Related Experiment Video
Updated: Aug 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipid-lowering therapy in patients with average cholesterol and high cardiovascular risk, insights from the Heart
1Department of Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, PO Box 3050, Doha, Qatar. amaramin@yahoo.com
Insights
The Heart Protection Study confirmed statins effectively reduce vascular events in diverse patient groups, including those with moderate or low cholesterol, women, and the elderly. This research provides crucial long-term safety and efficacy data for statin therapy.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Clinical Trials
Background:
- Established benefits of statins for high cholesterol and coronary heart disease.
- Uncertainty regarding long-term statin benefits in specific patient populations (moderate/low cholesterol, women, elderly, non-coronary vascular disease).
Purpose of the Study:
- To resolve uncertainties about long-term statin benefits in diverse patient groups.
- To gather extensive safety information on statin use.
Main Methods:
- The Heart Protection Study design.
- Inclusion of specific patient subgroups with moderate or low baseline cholesterol, women, the elderly, and those with prior occlusive non-coronary vascular disease.
Main Results:
- Statins demonstrated significant benefits across a broad range of patients.
- Comprehensive safety data for statin therapy was collected.
Conclusions:
- The study confirmed the broad efficacy and safety of statins.
- Results have significant practical implications for cholesterol-lowering treatment strategies.
Abstract:
Although the benefits of cholesterol-lowering with statins has been established for patients with high cholesterol levels as well as for patients with prior occlusive coronary heart disease, substantial uncertainty has existed about the long-term benefits of these agents in particular types of patient, including patients with moderate or low baseline cholesterol levels pre-treatment, women, the elderly, and those with prior occlusive non-coronary vascular disease. The Heart Protection Study was designed to resolve these uncertainties and to provide substantially more safety information of statins. In this report the study is presented with the significance and practical implications of the results briefly discussed.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...